MFDS — authorised 9 July 2021
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
MFDS authorised Kerendia on 9 July 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 9 July 2021.
BAYER HLTHCARE holds the South Korean marketing authorisation.